These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 38618037)

  • 21. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: Successful treatment of recurrent
    Johri AV; Johri P; Hoyle N; Nadareishvili L; Pipia L; Nizharadze D
    Front Pharmacol; 2023; 14():1243824. PubMed ID: 37790805
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental Phage Therapies in Companion Animals with A Historical Review.
    Pyzik E; Radzki RP; Urban-Chmiel R
    Curr Rev Clin Exp Pharmacol; 2021; 16(1):17-29. PubMed ID: 32223736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria.
    Sabouri Ghannad M; Mohammadi A
    Iran J Basic Med Sci; 2012 Mar; 15(2):693-701. PubMed ID: 23494063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Potential of Bacteriophage-Antibiotic Combination Therapy in Treating Infections with Multidrug-Resistant Bacteria.
    Osman AH; Kotey FCN; Odoom A; Darkwah S; Yeboah RK; Dayie NTKD; Donkor ES
    Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophage and antibiotic combination therapy for recurrent
    Stellfox ME; Fernandes C; Shields RK; Haidar G; Hughes Kramer K; Dembinski E; Mangalea MR; Arya G; Canfield GS; Duerkop BA; Van Tyne D
    mBio; 2024 Mar; 15(3):e0339623. PubMed ID: 38353560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage Therapy in Companion and Farm Animals.
    Bianchessi L; De Bernardi G; Vigorelli M; Dall'Ara P; Turin L
    Antibiotics (Basel); 2024 Mar; 13(4):. PubMed ID: 38666970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment.
    Chung KM; Liau XL; Tang SS
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage-Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency.
    Liu C; Hong Q; Chang RYK; Kwok PCL; Chan HK
    Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy.
    Oechslin F
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29966329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of experimental phage therapies in livestock.
    Dec M; Wernicki A; Urban-Chmiel R
    Anim Health Res Rev; 2020 Jun; 21(1):69-83. PubMed ID: 32618543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phages for Africa: The Potential Benefit and Challenges of Phage Therapy for the Livestock Sector in Sub-Saharan Africa.
    Makumi A; Mhone AL; Odaba J; Guantai L; Svitek N
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the potential of phage and their applications.
    Khambhati K; Bhattacharjee G; Gohil N; Maurya R; Singh V
    Prog Mol Biol Transl Sci; 2023; 200():1-12. PubMed ID: 37739550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriophage Effectively Rescues Pneumonia Caused by Prevalent Multidrug-Resistant
    Gan L; Fu H; Tian Z; Cui J; Yan C; Xue G; Fan Z; Du B; Feng J; Zhao H; Feng Y; Xu Z; Fu T; Cui X; Zhang R; Du S; Liu S; Zhou Y; Zhang Q; Cao L; Yuan J
    Microbiol Spectr; 2022 Oct; 10(5):e0235822. PubMed ID: 36165773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage steering of
    Ruest MK; Supina BSI; Dennis JJ
    J Bacteriol; 2023 Oct; 205(10):e0019623. PubMed ID: 37791751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into Bacteriophage Application in Controlling Vibrio Species.
    Letchumanan V; Chan KG; Pusparajah P; Saokaew S; Duangjai A; Goh BH; Ab Mutalib NS; Lee LH
    Front Microbiol; 2016; 7():1114. PubMed ID: 27486446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.